420 related articles for article (PubMed ID: 30872264)
1. A Transcriptionally Distinct CXCL13
Workel HH; Lubbers JM; Arnold R; Prins TM; van der Vlies P; de Lange K; Bosse T; van Gool IC; Eggink FA; Wouters MCA; Komdeur FL; van der Slikke EC; Creutzberg CL; Kol A; Plat A; Glaire M; Church DN; Nijman HW; de Bruyn M
Cancer Immunol Res; 2019 May; 7(5):784-796. PubMed ID: 30872264
[TBL] [Abstract][Full Text] [Related]
2. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
[TBL] [Abstract][Full Text] [Related]
3. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
[TBL] [Abstract][Full Text] [Related]
4. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
5. PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer.
Webb JR; Milne K; Nelson BH
Cancer Immunol Res; 2015 Aug; 3(8):926-35. PubMed ID: 25957117
[TBL] [Abstract][Full Text] [Related]
6. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.
Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH
Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978
[TBL] [Abstract][Full Text] [Related]
8. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.
Komdeur FL; Wouters MC; Workel HH; Tijans AM; Terwindt AL; Brunekreeft KL; Plat A; Klip HG; Eggink FA; Leffers N; Helfrich W; Samplonius DF; Bremer E; Wisman GB; Daemen T; Duiker EW; Hollema H; Nijman HW; de Bruyn M
Oncotarget; 2016 Nov; 7(46):75130-75144. PubMed ID: 27650547
[TBL] [Abstract][Full Text] [Related]
9. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.
Duhen T; Duhen R; Montler R; Moses J; Moudgil T; de Miranda NF; Goodall CP; Blair TC; Fox BA; McDermott JE; Chang SC; Grunkemeier G; Leidner R; Bell RB; Weinberg AD
Nat Commun; 2018 Jul; 9(1):2724. PubMed ID: 30006565
[TBL] [Abstract][Full Text] [Related]
11. Smad and NFAT pathways cooperate to induce CD103 expression in human CD8 T lymphocytes.
Mokrani M; Klibi J; Bluteau D; Bismuth G; Mami-Chouaib F
J Immunol; 2014 Mar; 192(5):2471-9. PubMed ID: 24477908
[TBL] [Abstract][Full Text] [Related]
12. CD103
Wang P; Huang B; Gao Y; Yang J; Liang Z; Zhang N; Fu X; Li L
Cell Immunol; 2018 Mar; 325():48-55. PubMed ID: 29448979
[TBL] [Abstract][Full Text] [Related]
13. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
El-Asady R; Yuan R; Liu K; Wang D; Gress RE; Lucas PJ; Drachenberg CB; Hadley GA
J Exp Med; 2005 May; 201(10):1647-57. PubMed ID: 15897278
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
15. PD-1
Li JP; Wu CY; Chen MY; Liu SX; Yan SM; Kang YF; Sun C; Grandis JR; Zeng MS; Zhong Q
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253636
[TBL] [Abstract][Full Text] [Related]
16. TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment.
Boutet M; Gauthier L; Leclerc M; Gros G; de Montpreville V; Théret N; Donnadieu E; Mami-Chouaib F
Cancer Res; 2016 Apr; 76(7):1757-69. PubMed ID: 26921343
[TBL] [Abstract][Full Text] [Related]
17. Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer.
Bösmüller HC; Wagner P; Peper JK; Schuster H; Pham DL; Greif K; Beschorner C; Rammensee HG; Stevanović S; Fend F; Staebler A
Int J Gynecol Cancer; 2016 May; 26(4):671-9. PubMed ID: 26905331
[TBL] [Abstract][Full Text] [Related]
18. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
Ukita M; Hamanishi J; Yoshitomi H; Yamanoi K; Takamatsu S; Ueda A; Suzuki H; Hosoe Y; Furutake Y; Taki M; Abiko K; Yamaguchi K; Nakai H; Baba T; Matsumura N; Yoshizawa A; Ueno H; Mandai M
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35552285
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CD103 expression on human colon carcinoma-specific CTL.
Ling KL; Dulphy N; Bahl P; Salio M; Maskell K; Piris J; Warren BF; George BD; Mortensen NJ; Cerundolo V
J Immunol; 2007 Mar; 178(5):2908-15. PubMed ID: 17312135
[TBL] [Abstract][Full Text] [Related]
20. Self-Maintaining CD103
Abd Hamid M; Colin-York H; Khalid-Alham N; Browne M; Cerundolo L; Chen JL; Yao X; Rosendo-Machado S; Waugh C; Maldonado-Perez D; Bowes E; Verrill C; Cerundolo V; Conlon CP; Fritzsche M; Peng Y; Dong T
Cancer Immunol Res; 2020 Feb; 8(2):203-216. PubMed ID: 31771983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]